Pathkey.ai Limited has released a press release.
Opyl - world-first mapping & linking clinical trial data
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Pathkey.AI
- Opyl Receives $570K R&D Tax Refund
- Opyl - Appendix 4E & Annual Report
- Opyl - FY22 Results Announcement
- Opyl 2021 AGM Presentation 18 November 2021
- Opyl - August Full Year Investor Update
Later from Pathkey.AI
- Suspension from Official Quotation
- Opyl completes Placement and launches Rights Issue
- Opyl enters into MSA and new clinical trial recruitment
- Appendix 4D & Half Year Results
- Successful Placement of Shortfall Shares from Rights Issue
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI